Trial Profile
Antiproteinuric Effects of Liraglutide Treatment in Patients with Type 2 Diabetes and Albuminuria: A Randomized, Placebo-Controlled Trial
Status:
Completed
Phase of Trial:
Phase IV
Latest Information Update: 06 Nov 2021
Price :
$35
*
At a glance
- Drugs Liraglutide (Primary)
- Indications Proteinuria; Type 2 diabetes mellitus
- Focus Therapeutic Use
- Acronyms LIRALBU
- 06 May 2016 Status changed from recruiting to completed as per European Clinical Trials Database record.
- 09 Apr 2015 New trial record